THAPAR
Emcure has better listed pharma alternatives
Emcure Pharma, with its strong presence in gynaecology and HIV therapeutic areas, secured significant investments from anchor investors like HDFC Mutual Fund and ICICI Prudential Mutual Fund, showcasing immense market confidence in its upcoming IPO.
Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of subscription
Emcure Pharmaceuticals' IPO opens for subscription on July 3rd with shares trading at a Rs 265 premium in the unlisted market. The IPO includes fresh equity shares worth Rs 800 crore and an Offer For Sale (OFS) of 1.14 crore shares. Priced at Rs 960-1,008 per share, investors can bid for 14 shares per lot. The company targets to raise Rs 1,952 crore at the upper price range.
Shark tank fame Namita Thapar to rake in Rs 127 crore through Emcure Pharma IPO
Shark Tank's Namita Thapar, who is part of Emcure Pharmaceuticals' promoter group, is set to earn approximately Rs 127 crore through the upcoming IPO. Thapar, who acquired shares in Emcure at an average price of Rs 3.44 each, will sell around 12.68 lakh shares through the OFS component of the IPO. With the upper price band set at Rs 1,008 per share, the stake sale is expected to yield about Rs 127 crore.
Ola Electric, Emcure Pharma get Sebi nod for IPOs, setting stage for big listings
The Bengaluru-based company had filed its draft prospectus with Sebi in December last year. The issue comprises a fresh equity sale of Rs 5,500 crore and an offer-for-sale (OFS) of 95.2 million shares.
Thapar Institute to submit proposal to Isro to launch its first student satellite 'Thaparsat'
TIET plans to launch 'Thaparsat' with Isro to monitor pollution and soil moisture in north India, enhancing student learning in engineering and technology.
Prashant Kishor responds to row over Karan Thapar interview, says keep plenty of water handy on June 4th
Political strategist Prashant Kishor responded to a viral interview by emphasizing the importance of staying hydrated, stating, "Drinking water is good as it keeps both mind and body hydrated." The interview with veteran journalist Karan Thapar saw Kishor denying predictions attributed to him about Congress' defeat. The exchange has sparked widespread discussion on social media.
- Go To Page 1
Emcure and its subsidiary Gennova settle legal dispute with HDT Bio over mRNA technology
Emcure Pharmaceuticals and its subsidiary Gennova have resolved all legal disputes with US-based HDT Bio Corp. The parties have entered into a long-term agreement to develop mRNA vaccines against various infectious diseases in India and other countries. As part of their agreement, HDT has granted a license to Gennova to use HDT's patented mRNA vaccine technology in multiple fields
Why Prashant Kishor and Karan Thapar are trending on social media
A viral video shows journalist Karan Thapar confronting political strategist Prashant Kishor with past tweets predicting Congress's defeat in Himachal Pradesh and Telangana. Kishor denied these predictions, appearing upset. Despite the tension, Kishor forecasted BJP winning 300 seats in the 2024 Lok Sabha elections and offered advice to Rahul Gandhi. The video sparked widespread social media reactions.
A starter library for entrepreneurs, as recommended by Popcorn and Company’s Vikas Suri
Vikas Suri, CEO and founder, Popcorn and Company, is an ardent reader of business books but there is one line – from Mike Michalowicz’s Profit First – that has left the greatest impact.
Bajaj Auto aims to make 10,000 Triumph units a month by September, CFO says
Bajaj Auto targets 10,000 units monthly for Triumph motorcycles by September, with a robust financial performance driven by rural India's demand for entry-level models and steady mid-level motorcycle sales.
Nita Ambani previously shared her views on the value of money
Given that Mukesh Ambani is the richest person in India, it seems sense that many people in the nation hold him and his family in high regard. People find the Ambanis fascinating, and they frequently make news for both their personal and business life.
‘Shark Tank India’ judge Namita Thapar silences trolls who claimed she succeeded with ‘daddy’s money’
The entrepreneur, who recently held an ‘Ask Me Anything’ session on Reddit, was initially taken aback when a Reddit user attacked her personally, stating that she would be nowhere without the support of her father Satish Mehta, the founder of Emcure Pharmaceuticals.
'Shark Tank India' judge Namita Thapar candidly opens up about perimenopause struggles during show: Watch
Namita Thapar, the executive director of Emcure Pharmaceuticals and a judge on Shark Tank India, recently shared her personal struggles with perimenopause during an episode of the show. She spoke openly about experiencing heavy bleeding and discomfort, leading to anaemia. Thapar's candid disclosure prompted widespread support and dialogue on social media, highlighting the importance of destigmatizing discussions surrounding women's health.
'Shark Tank India' judge Namita Thapar teases project with MS Dhoni, shares pics
Namita Thapar, renowned business figure and 'Shark Tank India' judge, recently hinted at an upcoming collaboration with cricket icon MS Dhoni, sparking excitement among fans. The duo's stylish photos together have left followers eagerly anticipating further details about their joint venture. As Thapar continues to mentor entrepreneurs on the show, this unexpected partnership with Dhoni promises a fusion of business acumen and glamour.
Emcure Pharma to launch IPO in 3 months: Namita Thapar of Shark Tank fame
Shark Tank fame and Executive Director of Emcure Pharmaceuticals, Namita Thapar said at the ET NOW Global Business Summit 2024 on February 10 that the company plans to go public within three months.
Burger Singh raises fresh funding from Turner Morrison, existing investors
Burger Singh said in a media statement that the new round of funding saw participation from existing investors including Anicut Capital’s Ashvin Chadha, Thapar Family Trust’s Vikramaditya Mohan Thapar, Mumbai Angels and LetsVentures.
70-hour work week: Shark Tank's Namita Thapar says when 'will we ever find time for family'
The debate was ignited by N. R. Narayana Murthy, co-founder of Infosys, who suggested that young people should work 70 hours a week to boost India's productivity. In a podcast conversation with former Infosys CFO Mohandas Pai, Murthy argued that India's work productivity is among the lowest in the world.
World Mental Health Day: From Aamir Khan to ‘Shark Tank India’ judge Namita Thapar, 3 public figures share mental well-being hacks
As Mental Health Day draws to an end, let us remember, that no one, including those who we look up to and try to emulate, are free from struggles with mental health.
Bengaluru college students brave floods and typhoid to honor Kargil martyrs
Two college students from Bengaluru, Krishnan A and Peddi Sai Kaushik, cycled over 3,200 km in over 60 days to pay homage to the martyrs at the war memorial on Kargil Vijay Diwas. The duo, who are both National Cadet Corps (NCC) cadets and aspire to join the armed forces, started their journey on the Kanyakumari-Srinagar highway in May and aimed to complete it before the monsoon season. They overcame setbacks, illnesses and difficulties to honor the martyrs and raise awareness about the sacrifices made by soldiers.
Shark Tank India Season 1 | Over 40% of investment deals were closed: PrivateCircle report
Over a year after Shark Tank India Season 1 aired on television, seven of the so-called sharks (investors) completed only 27 of the 65 soft commitments that they had agreed to deploy in startups that participated in the show, according to an analysis by PrivateCircle Research.
By merging tech with botany, can one plant be an effective air purifier?
UBreathe provides a green alternative to traditional indoor mechanical purifiers by enhancing the performance of normal plants.
Martyrs' Day 2023: History, dates, significance and more
India observes Martyrs' Day every year on March 23 to honor the sacrifices of brave soldiers and freedom fighters who gave their lives for the country's independence.
Shark Tank judge Namita Thapar talks about her struggles with IVF, says 'I gave up, took 25 Injections'
In that particular episode, the pitch presented by the contestant focused on the issue of infertility that women face, and that's when Namita talked about her struggles.
Teen freelancing startup Funngro raises funding from Shark Tank judges Amit Jain, Namita Thapar
Funngro, which offers teenagers an opportunity to earn money through real-life freelancing projects, was first incubated at India’s first fintech incubator Afthonia Lab in 2021 and has a network of four lakh teenlancers (teenagers who are freelancers) and over 1,000 companies.
Shark Tank India 2: Peyush Bansal tells e-clinic pitchers, accepting Namita Thapar's offer was their "biggest mistake"
In the most recent episode of Shark Tank India 2, Namita Thapar and Peyush Bansal have a verbal spat over a pitch.
Peyush Bansal reveals Vineeta Singh's passion of running on 'The Kapil Sharma Show'
Peyush Bansal said that Vineeta Singh enjoys running and that he once spotted her running at 12 a.m. after the show's shoot.
Shark Tank India 2: Over Rs 42 crore in investment so far, Namita Thapar leads the race
Shark Tank India 2 has received an investment of Rs. 42.93 crore after five weeks, with Namita Thapar, Peyush Bansal, and Aman Gupta leading the way.
'Shark Tank India 2': VS Mani wins over Anupam Mittal & Namita Thapar, founder GD Prasad posts emotional 'thank you' note
Prasad said they have been flooded with congratulatory messages since their TV debut.
Load More
